Sarcoma and GIST Cancer Translational Research Disease Group

Understanding the genetic alterations that lead to sarcoma and GIST cancer is essential to fighting the disease. At Fox Chase, a multidisciplinary team of researchers and clinicians meets regularly to review translational research initiatives to identify and characterize new biomarkers of sarcoma and GIST cancers that lead to new, innovative prevention and targeted therapy options for our patients.